Ministry of Health has emphasized that the use of Sulphadoxine Pyrimethamine (SP) to fight Malaria in general population is unviable due to a 32% decline in the drug’s efficiency and efficacy, which falls below WHO recommendations.
Secretary for Health in the Ministry of Health, Dr Samson Mndolo, says following the phasing out of SP in treating Malaria, Malawi adopted Artemether Lumefantrine (LA) in 2017 as a preventive measure against Malaria.
Dr Mndolo further says the continued use of SP drugs in the country is not in line with the Ministry’s policy in the fight against Malaria and health practitioners who are not conversant with current policies on Malaria are called to seek guidance from relevant authorities.
By Alufisha Fischer
